文章基本信息

标题：A high-throughput liquid bead array assay confirms strong correlation between SARS-CoV-2 antibody level and COVID-19 severity
本地全文：下载
作者：Monique Bennett ; Sandra Yoder ; Eric Brady 等
期刊名称：iScience
印刷版ISSN：2589-0042
出版年度：2021
卷号：24
期号：2
页码：1-16
DOI：10.1016/j.isci.2021.102052
语种：English
出版社：Elsevier
摘要：SummaryA detailed understanding of the adaptive host response to SARS-CoV-2 infection in humans is urgently needed. We developed a sensitive, high-throughput, and efficient assay using liquid bead array technology. We observed advantages over traditional ELISA for the detection and quantification of binding IgG against the receptor binding domain (RBD) of SARS-CoV-2. To determine whether COVID-19 symptom severity correlates with SARS-CoV-2 IgG, we measured anti-RBD IgG levels from 67 subjects recovered from PCR-confirmed COVID-19. We found that COVID-19 symptom severity strongly correlated with RBD IgG level (p < 0.001). These findings have substantial implications for public policy surrounding assessments of antibody responses and possible immunity, as not all cases of COVID-19 can be assumed to generate a protective antibody response, and mild disease in particular is capable of generating very low-level anti-RBD IgG levels. These findings also have important implications for the selection of donors for convalescent plasma to be used therapeutically.Graphical abstractDisplay OmittedHighlights•We developed a sensitive, high-throughput assay for quantification of SARS-CoV-2 IgG•The assay uses liquid bead array technology for efficient and reproducible results•COVID-19 symptom severity was strongly correlated with SARS-CoV-2 SRBDIgG levelsBiological Sciences; Microbiology; Virology; Viral Microbiology